J. Hansen

D. Stirewalt, J. Hansen, E. Petersdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.

H. Deeg, R. Storb, F. Appelbaum, 1986, Blood.

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis

M. Sarwal, J. Pidala, Stephanie J. Lee, 2016, The journal of pathology. Clinical research.

Evidence for a multistep pathogenesis of chronic myelogenous leukemia.

V. Najfeld, J. Hansen, P. Martin, 1981, Blood.

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.

J. Armitage, P. Bierman, J. Vose, 1991, The New England journal of medicine.

HLA-Cw*0409N is associated with HLA-A*2301 and HLA-B*4403-carrying haplotypes.

J. Hansen, C. Larsen, A. Smith, 2004, Human immunology.

QB 1 * 0301 and DQB 1 * 0601 Modulate arcolepsy Susceptibility in Koreans

J. Hansen, Ling Lin, Jing Zhang, 2007 .

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.

H. Mcdevitt, C. Jacob, J. Hansen, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

H. Deeg, J. Radich, S. Heimfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.

K. Sullivan, R. Storb, F. Appelbaum, 1996, Blood.

K. Sullivan, R. Storb, F. Appelbaum, 1996, British journal of haematology.

Human T cell activation: differential response to anti‐CD28 as compared to anti‐CD3 monoclonal antibodies

J. Hansen, S. Sung, S. Fu, 1989, European journal of immunology.

Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes.

J. Hansen, A. Farr, O. Press, 1988, Cancer research.

HLA DNA typing and transplantation.

H. Erlich, J. Hansen, G. Opelz, 2001, Immunity.

Evidence for a multistep pathogenesis of chronic myelogenous leukemia.

V. Najfeld, P. Fialkow, J. Hansen, 1981 .

Cell surface antigens of human melanoma identified by monoclonal antibody.

J. Brown, J. Hansen, I. Hellstrom, 1979, Proceedings of the National Academy of Sciences of the United States of America.

DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans.

E. Mignot, Seung-Chul Hong, Anajane G. Smith, 2007, Human immunology.

Increased Apoptosis of Peripheral Blood T Cells following Allogeneic Hematopoietic Cell Transplantation

J. Hansen, T. Gooley, H. Frangoul, 2022 .

Hematopoietic stem cell transplants from unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1997, Immunological reviews.

Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.

Colin J. Brown, J. Ragoussis, K. Osoegawa, 2019, Human immunology.

Immunogenetic aspects of allotransplantation.

J. Hansen, B. Dupont, E. Yunis, 1976, Advances in experimental medicine and biology.

Duration of immunosuppressive treatment for chronic graft-versus-host disease.

R. Storb, B. Storer, F. Appelbaum, 2004, Blood.

Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.

K. Sullivan, R. Storb, D. Maloney, 1997, Blood.

Genetic risk factors for sclerotic graft-versus-host disease.

L. Zhao, B. Storer, E. Warren, 2014, Blood.

B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.

C. Bloomfield, J. Hansen, R. Good, 1973, The Journal of clinical investigation.

Marrow grafting for acute leukemia: results and future treatment strategies.

R. Storb, F. Appelbaum, J. Hansen, 1990, Haematology and blood transfusion.

Trends in transplantation of hematopoietic stem cells from unrelated donors.

J. Hansen, E. Petersdorf, C. Anasetti, 2001, Current opinion in hematology.

Oligonucleotide arrays for high-throughput SNPs detection in the MHC class I genes: HLA-B as a model system.

L. Hood, J. Hansen, E. Petersdorf, 2002, Genome research.

Six new DR52-associated DRB1 alleles, three of DR8, two of DR11, and one of DR6, reflect a variety of mechanisms which generate polymorphism in the MHC.

E. Donadi, J. Hansen, A. Smith, 1996, Tissue antigens.

Two new DR52-associated alleles, DRB1*1111 and *1312, identified by PCR/SSOP and confirmed by DNA sequencing.

J. Hansen, A. Smith, C. Brautbar, 1994, Tissue antigens.

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.

R. Storb, F. Appelbaum, J. Hansen, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of ricin A-chain immunotoxins directed against human T cells.

J. Hansen, A. Farr, E. Vitetta, 1986, Cellular immunology.

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, F. Appelbaum, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Homotypic aggregation of human cell lines by HLA class II‐, class Ia‐ and HLA‐G‐specific monoclonal antibodies

J. Ledbetter, D. Geraghty, J. Hansen, 1991, European journal of immunology.

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.

B. Storer, Anajane G. Smith, J. Hansen, 2001, The New England journal of medicine.

New advances in hematopoietic cell transplantation

J. Hansen, E. Petersdorf, 2008, Current opinion in hematology.

Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules

J. Hansen, S. Yoon Choo, L. Fan, 2004, Immunogenetics.

A MODEL FOR DISEASE HETEROGENEITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: Relationships Between Histocompatibility Antigens, Autoantibodies, and Lymphopenia or Renal Disease

J. Harley, J. Hansen, M. Reichlin, 1989, Arthritis and rheumatism.

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

J. Hansen, P. Beatty, R. Champlin, 1993, The New England journal of medicine.

Surgical adjuvant therapy of malignant melanoma with Corynebacterium parvum

H. Wanebo, J. Hansen, Y. Hirshaut, 1981, Cancer.

Proteomic Characterization Reveals That MMP‐3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation

Philip R. Gafken, Y. Ogata, P. Gafken, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis

S. Holbeck, J. Hansen, G. Nepom, 1986, The Journal of experimental medicine.

Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus.

D. Monos, J. Hansen, M. Kamoun, 1988, Human immunology.

The Graft-vs.-Host Reaction in Man

J. Woodruff, J. Hansen, R. Good, 1981 .

Association of four HLA class III region genomic markers with HLA haplotypes.

J. Strominger, J. Hansen, T. Spies, 1991, Tissue antigens.

The Antibody Response to Insulin Therapy: A Prospective Study in HLA-typed Insulin-dependent Diabetic Subjects

J. Hansen, J. Palmer, T. Dornan, 1984, Diabetes.

Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.

R. Storb, F. Appelbaum, G. Schoch, 1997, Blood.

A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA.

J. Hansen, A. Smith, E. Mickelson, 1993, Tissue antigens.

Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization.

P. Lingenfelter, J. Hansen, M. Bean, 1995, Blood.

Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis.

Anajane G. Smith, J. Hansen, A. Smith, 1993, The New England journal of medicine.

Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.

H. Deeg, K. Sullivan, J. Hansen, 1988, Bone marrow transplantation.

Marrow transplantation from unrelated volunteer donors.

Ruth Etzioni, J. Hansen, E. Petersdorf, 1995, Annual review of medicine.

Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.

J. Hansen, G. Nepom, B. Nepom, 1983, Proceedings of the National Academy of Sciences of the United States of America.

A specific nucleotide sequence defines a functional T-cell recognition epitope shared by diverse HLA-DR specificities.

J. Hansen, G. Nepom, E. Mickelson, 1988, Human immunology.

A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire.

J. Hansen, H. Sao, P. Martin, 1989, Journal of immunology.

Related or unrelated donor.

J. Hansen, 2012, Blood.

Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes

Ming-Tseh Lin, B. Storer, J. Hansen, 2008, Immunologic research.

Tissue typing in support of unrelated hematopoietic cell transplantation.

J. Hansen, E. Petersdorf, C. Anasetti, 2003, Tissue antigens.

Impact of molecular histocompatibility typing on outcome of unrelated donor hematopoietic cell transplantation

J. Hansen, E. Petersdorf, C. Anasetti, 2002 .

Genomics of unrelated-donor hematopoietic cell transplantation.

Ming-Tseh Lin, Anajane G. Smith, J. Hansen, 2001, Current opinion in immunology.

The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation

Anajane G. Smith, J. Hansen, M. Malkki, 2001, British journal of haematology.

Improving availability and safety of unrelated donor transplants

J. Hansen, E. Petersdorf, C. Anasetti, 2000, Current opinion in oncology.

HLA matching in hematopoietic cell transplantation.

J. Hansen, E. Petersdorf, C. Anasetti, 2000, Human immunology.

Transplantation of hematopoietic stem cells from unrelated volunteer donors.

J. Hansen, E. Petersdorf, C. Anasetti, 2000, Transplantation proceedings.

J. Hansen, E. Petersdorf, C. Anasetti, 1999, Cancer treatment and research.

Definition of HLA-DQ as a transplantation antigen.

G. Longton, J. Hansen, A. Smith, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.

G. Longton, Anajane G. Smith, J. Hansen, 1995, Blood.

Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

G. Kraft, T. Kalina, K. Sullivan, 2004, Clinical immunology.

Disparity for a newly identified minor histocompatibility antigen, HA‐8, correlates with acute graft‐versus‐host disease after haematopoietic stem cell transplantation from an HLA‐identical sibling

Ming-Tseh Lin, V. Engelhard, E. Warren, 2003, British journal of haematology.

Definition of a common leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions.

J. Ledbetter, J. Hansen, P. Beatty, 1983, Journal of immunology.

Recognition by a murine monoclonal antibody of a unique epitope specific for the human alloantigen HLA-B8.

J. Hansen, B. Nisperos, P. Antonelli, 1984, Human immunology.

Polymorphism in the tumor necrosis factor gene: Association with HLA-B and DR haplotypes

J. Strominger, J. Hansen, T. Spies, 1988 .

A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing.

J. Hansen, E. Petersdorf, 1995, Tissue antigens.

Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.

J. Hansen, A. Smith, E. Petersdorf, 1994, Tissue antigens.

Tryptic peptide mapping identifies structural heterogeneity among six variants of HLA-B27

J. Hansen, G. Nepom, S. Choo, 2004, Immunogenetics.

Identification of the rs9277534 HLA-DP expression marker by next generation sequencing for the selection of unrelated donors for hematopoietic cell transplantation.

J. Hansen, E. Petersdorf, L. Regen, 2019, Human immunology.

Examination of four HLA class I pseudogenes. Common events in the evolution of HLA genes and pseudogenes.

B. Koller, D. Geraghty, J. Hansen, 1992, Journal of immunology.

9.7-03 Association of four class III genomic markers mapping near TNF with extended HLA-A-B-DR haplotypes

J. Strominger, J. Hansen, T. Spies, 1989 .

The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules

J. Silver, J. Hansen, S. Goyert, 1984, The Journal of experimental medicine.

Human Immune Response Genes

J. Hansen, G. Nepom, 1985 .

Selection of an unrelated donor for marrow transplantation facilitated by the molecular characterization of a novel HLA-A allele.

J. Hansen, C. Anasetti, S. Choo, 1993, Human immunology.

A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain.

J. Hansen, S. Choo, L. Fan, 1991, Journal of immunology.

The Dai minority population of southwest China: heterogeneity of DR2-associated HLA-DRB1,DRB5,DQA1, and DQB1 haplotypes.

J. Hansen, A. Smith, D. Chandanayingyong, 1996, Human immunology.

Molecular diversity of the HLA-C locus in unrelated marrow transplantation.

J. Hansen, E. Petersdorf, P. Martin, 1994, Tissue antigens.

HLA-DRB1 first domain sequences of two new DR11 alleles and one novel DR4 allele.

J. Hansen, A. Smith, E. Petersdorf, 1993, Tissue antigens.

HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413.

J. Hansen, A. Smith, E. Petersdorf, 1992, Tissue antigens.

Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines.

Y. Obata, J. Hansen, Y. Morishima, 2002, Tissue antigens.

DQw3 variants defined by cloned alloreactive T cells.

J. Hansen, G. Nepom, B. Nisperos, 1988, Human immunology.

Identification of a human T lymphocyte surface protein associated with the E-rosette receptor

J. Hansen, M. Kamoun, M. Brown, 1981, The Journal of experimental medicine.

Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression.

P. Rabinovitch, M. Parsons, C. June, 1986, Journal of immunology.

The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1.

T. Strom, H. Shapiro, R. Loertscher, 1985, Journal of immunology.

Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study.

J. Hansen, R. Nowinski, P. Martin, 1981, Journal of immunology.

Beta-Cell Dysfunction in Nondiabetic HLA Identical Siblings of Insulin-Dependent Diabetics

J. Hansen, J. Palmer, C. Asplin, 1982, Diabetes.

Adverse outcomes after preterm labor are associated with tumor necrosis factor-alpha polymorphism -863, but not -308, in mother-infant pairs.

Ming-Tseh Lin, J. Hansen, J. Hitti, 2004, American journal of obstetrics and gynecology.

HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.

J. Hansen, E. Petersdorf, T. Gooley, 1998, Biology of Blood and Marrow Transplantation.

HLA homozygosity and the risk of graft-versus-host disease.

J. Hansen, E. Petersdorf, C. Anasetti, 1997, Tissue antigens.

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

M. Pepe, K. Sullivan, R. Storb, 1991, Transplantation.

ALLOREACTIVE T CELL RESPONSES BETWEEN HLA‐IDENTICAL SIBLINGS: DETECTION OF ANTI‐MINOR HISTOCOMPATIBILITY T CELL CLONES INDUCED IN VIVO

J. Hansen, P. Beatty, E. Thomas, 1985, Transplantation.

Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.

H. Deeg, C. Dinarello, Xiang Li, 2011, Blood.

Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16).

P. Rabinovitch, C. June, J. Ledbetter, 1987, Journal of immunology.

Genetic and immunological markers of insulin dependent diabetes in Black Americans.

W. Hagopian, A. Kitabchi, J. Hansen, 1995, Autoimmunity.

Brief Definitive Report Specific Genomic Markers for the Hla-dq Subregion Discriminate between Dr4 + Insulin- Dependent Diabetes Mellitus and Dr4 + Seropositive Juvenile Rheumatoid Arthritis

S. Holbeck, J. Hansen, G. Nepom, 2003 .

Fecundity before disease onset in women with rheumatoid arthritis.

T. Koepsell, J. Hansen, J. Daling, 1993, Arthritis and rheumatism.

HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes.

J. Hansen, G. Nepom, E. Mickelson, 2008, Tissue antigens.

Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA.

J. Hansen, A. Smith, L. Tseng, 1998, Tissue antigens.

Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation.

D. Schwartz, J. Hansen, J. Clark, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFα and TNFβ genes

Ming-Tseh Lin, Pei-Jer Chen, J. Hansen, 2002 .

Molecular analysis of the variant alloantigen HLA-B27d (HLA-B*2703) identifies a unique single amino acid substitution.

H. Orr, J. Hansen, S. Choo, 1988, Human immunology.

Electrophoretic variation between class II molecules expressed on HLA-DRw8 homozygous typing cells reveals multiple distinct haplotypes

J. Hansen, G. Baldwin, G. Nepom, 2004, Immunogenetics.

Two new DR2 alleles: DRB1*1607 identified in an Ashkenazi Jewish family and DRB1*15022 found in a single Caucasian donor.

J. Hansen, A. Smith, C. Brautbar, 1997, Tissue antigens.

Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex.

H. Ochs, J. Hansen, B. Dupont, 1977, The New England journal of medicine.

Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.

Anajane G. Smith, J. Hansen, A. Smith, 1998, Blood.

DRB1*1504 (DR2Dai): a new DR2 allele identified in the Dai minority population of southwest China.

J. Hansen, A. Smith, D. Chandanayingyong, 1994, Tissue antigens.

Lipopolysaccharide binding protein promoter variants inﬂuence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation

J. Hansen, J. Chien, M. Boeckh, 2008 .

Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.

J. Hansen, G. Nepom, W. Kwok, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.

H. Deeg, K. Sullivan, R. Storb, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase

K. Sullivan, R. Storb, F. Appelbaum, 1998 .

Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.

K. Sullivan, R. Storb, F. Appelbaum, 1998, Blood.

FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.

J. Fay, H. Deeg, K. Sullivan, 1996, Blood.

Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations.

R. Carlsen, J. Hansen, R. Barrington, 1994, The Journal of rheumatology.

HLA antigens in Tlingit Indians with rheumatoid arthritis.

J. Hansen, R. Barrington, A. Smith, 1992, Tissue antigens.

The HLA system in Inupiat and Central Yupik Alaskan Eskimos.

J. Hansen, A. Lanier, E. Mickelson, 1986, Human immunology.

HLA antigens in Yakima Indians with rheumatoid arthritis. Lack of association with HLA-Dw4 and HLA-DR4.

J. Hansen, B. Nisperos, J. Malmgren, 1982, Arthritis and rheumatism.

Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6.

B. Sandmaier, M. Boeckh, J. Hansen, 2017, Blood.

PROBABILITY OF FINDING HLA‐MATCHED UNRELATED MARROW DONORS

J. Hansen, P. Beatty, G. Opelz, 1988, Transplantation.

B-Lymphoid cell lines derived fromHLA-D homozygous donors

R. Winchester, H. Kunkel, J. Hansen, 1979, Immunogenetics.

Phenotyping human leukemic T-Cell lines: Enzyme markers; surface antigens, and cytogenetics

J. Hansen, Paul J. Martin, E. Giblett, 2004, Immunogenetics.

Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin.

B. Storer, C. Dinarello, J. Hansen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

S. Hanash, B. Storer, Chee-Hong Wong, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161 hi CD8 (cid:1) (cid:2) semi-invariant T cells

S. Heimfeld, C. Turtle, S. Riddell, 2011 .

Analysis of the HLA-DRw8 haplotype: Recognition by HTC typing of three distinct antigen complexes in Caucasians, Native Americans, and Orientals

J. Hansen, Z. Layrisse, B. Nisperos, 2004, Immunogenetics.

Polymorphisms within the tumor necrosis factor and lymphotoxin-alpha genes and endemic pemphigus foliaceus--are there any associations?

M. Petzl-Erler, J. Hansen, D. P. Pavoni, 2003, Tissue antigens.

Transplantation of marrow from an unrelated donor to a patient with acute leukemia.

R. Storb, J. Hansen, E. Thomas, 1980, The New England journal of medicine.

A comparative study of HLA-DRB typing by transcription-mediated amplification with the hybridization protection assay (TMA/HPA) versus PCR/SSOP.

J. Hansen, A. Smith, K. Matsubara, 1997, Human Immunology.

Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors.

E. Engleman, J. Hansen, N. Damle, 1983, Journal of immunology.

T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets

R. Storb, J. Hansen, K. Atkinson, 1982 .

Quantitative assays for detection of residual T cells of T-depleted human marrow.

J. Hansen, P. Martin, 1985, Blood.

A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro.

J. Hansen, E. Vitetta, P. Martin, 1985, Blood.

Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor

F. Appelbaum, J. Singer, J. Hansen, 1993 .

Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens.

J. Ledbetter, J. Hansen, P. Martin, 1983, Blood.

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.

T. Waldmann, H. Deeg, R. Storb, 1994, Blood.

HLA, Blood Transfusion and the Immune System

J. Hansen, S. Slichter, G. Gjerset, 1984, Clinics in Immunology and Allergy.

HLA-DR antigens on lymphoid cells differ from those on myeloid cells

J. Hansen, G. Nepom, B. Nepom, 1983, Nature.

Chapter 2 – Monoclonal Antilymphocyte Antibodies: Probes for the Study of the Regulation of Hematopoiesis and Potential Clinical Applications1

J. Hansen, Paul J. Martin, B. Torok-Storb, 1983 .

Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.

C. June, J. Ledbetter, J. Hansen, 1986, Journal of immunology.

Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.

J. Hansen, S. Schwartz, A. Svejgaard, 1977, The New England journal of medicine.

RECOGNITION BY PREGNANCY SERUMS OF SEVERAL DISTINCT NON-HL-A ALLOANTIGENS EXPRESSED ON B CELLS AND THEIR RELATIONSHIP TO LD DETERMINANTS

R. Winchester, H. Kunkel, P. Wernet, 1976 .

Clinical Marrow Transplantation

J. Hansen, P. Beatty, Paul J. Martin, 1987 .

Histocompatibility and marrow transplantation.

R. Storb, J. Hansen, E. Thomas, 1979, Transplantation Proceedings.

Marrow transplantation from donors other than HLA-identical siblings.

R. Storb, J. Singer, J. Hansen, 1979, Transplantation.

The pathology of the graft-versus-host reaction (GVHR) in adults receiving bone marrow transplants.

J. Woodruff, J. Hansen, R. Good, 1976, Transplantation Proceedings.

Studies of T Cell Proliferation Induced by Monoclonal Antibodies of the Second International Workshop

E. Clark, J. Ledbetter, J. Hansen, 1986 .

Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody.

J. Hansen, G. Miller, E. Thomas, 1984, Annals of internal medicine.

Allogeneic bone marrow transplantation for chronic granulocytic leukemia.

R. Storb, J. Singer, J. Hansen, 1981, Experimental hematology.

Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.

J. Nemunaitis, R. Storb, C. Higano, 1991, Blood.

Biomarkers in chronic graft-versus-host disease: quo vadis?

E. Weissinger, E. Holler, J. Hansen, 2018, Bone Marrow Transplantation.

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013 .

Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.

B. Storer, E. Warren, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A monoclonal antibody recognizing a determinant shared by HLA-A2 and HLA-Aw69 (A28* variant).

J. Hansen, S. Choo, B. Nisperos, 2008, Tissue antigens.

A supertypic HLA-DR specificity (DR4+5) defined by murine monoclonal antibody.

J. Hansen, M. Kamoun, E. Thomas, 1981, Human immunology.

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.

H. Deeg, B. Sandmaier, F. Appelbaum, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

H. Deeg, J. Hansen, Paul J. Martin, 1985 .

Monoclonal antibody 9.3 and anti‐CD11 antibodies define reciprocal subsets of lymphocytes

J. Hansen, P. Beatty, Paul J. Martin, 1985, European journal of immunology.

Malignant disease of the lymphoid system in immunological perspective.

J. Hansen, R. Good, 1974, Human pathology.

Variants of HLA-DRw52 defined by T lymphocyte clones.

J. Hansen, E. Mickelson, S. Masewicz, 1988, Human immunology.

The HLA system in the Korean population.

J. Hansen, E. Giblett, I. Choi, 1986, Human immunology.

Association between giant cell (temporal) arteritis and HLA-Cw3.

L. A. Healey, J. Hansen, K. Wilske, 1985, Human immunology.

HLA-DR2 and DR4 further defined by two new HLA-D specificities (HTC) derived from Israeli Jewish donors: comparative study in Caucasian, Korean, Eskimo and Israeli populations.

J. Hansen, A. Lanier, C. Brautbar, 1984, Tissue antigens.

Multiple Ia-like molecules characterize HLA-DR2-associated haplotypes which differ in HLA-D.

M. Wilson, J. Hansen, G. Nepom, 1984, Human immunology.

Definition of LD "4 X 7": a unique HLA-D specificity defined by two homozygous typing cells.

J. Hansen, E. Thomas, E. Mickelson, 1982, Human immunology.

Two homozygous typing cells defining a subgroup of HLA-Dw6.

J. Hansen, E. Mickelson, B. Nisperos, 1980, Human immunology.

The molecular basis for HLA class II associations with rheumatoid arthritis

J. Hansen, G. Nepom, B. Nepom, 2004, Journal of Clinical Immunology.

Evolution of epitopes on human and nonhuman primate lymphocyte cell surface antigens

E. Clark, J. Ledbetter, J. Hansen, 2004, Immunogenetics.

Human T Lymphocyte Cell Surface Molecules Defined by the Workshop Monoclonal Antibodies (“T Cell Protocol”)

E. Clark, J. Ledbetter, J. Hansen, 1984 .

The cell surface phenotype of a naturally occurring human suppressor T-cell of restricted specificity: definition by monoclonal antibodies.

J. Hansen, Y. Takahashi, P. Martin, 1983, Journal of immunology.

T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets.

R. Storb, J. Hansen, K. Atkinson, 1982, Blood.

Regulation of in vitro erythropoiesis by normal T cells: evidence for two T-cell subsets with opposing function.

J. Hansen, P. Martin, B. Torok-Storb, 1981, Blood.

Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes.

P. Taillon-Miller, Benjamin A Lipsky, D. Chaplin, 1992, Proceedings of the National Academy of Sciences of the United States of America.

A randomized trial of antihuman thymocyte globulin versus murine monoclonal antihuman T-cell antibodies as immunosuppressive therapy for aplastic anemia.

R. Storb, F. Appelbaum, J. Hansen, 1985, Experimental hematology.

Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study

J. Bolaños-Meade, Yi-Bin Chen, J. Hansen, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

B. Storer, J. Hansen, G. McDonald, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of acute GVHD treatment outcomes 1 PREDICTIVE VALUE OF CLINICAL FINDINGS AND PLASMA BIOMARKERS AFTER 14 DAYS OF PREDNISONE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE

B. Storer, J. Hansen, G. McDonald, 2017 .

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.

B. Storer, J. Hansen, G. McDonald, 2015, Blood.

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.

R. Storb, F. Appelbaum, G. Schoch, 1990, Blood.

Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass.

I. Bernstein, J. Hansen, C. Anasetti, 1987, Journal of immunology.

Population genetics for five HLA-D determinants in caucasians (New York City).

J. Hansen, B. Dupont, C. Whitsett, 1977, Transplantation proceedings.

Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families

H. Kunkel, N. Day, J. Hansen, 1975, The Journal of experimental medicine.

Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.

R. Storb, F. Appelbaum, J. Hansen, 1993, Blood.

The HLA system in clinical marrow transplantation.

D. Geraghty, J. Hansen, S. Choo, 1990, Hematology/oncology clinics of North America.

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

T. Hohl, B. Storer, E. Warren, 2017, Blood.

A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes.

C. June, J. Ledbetter, J. Hansen, 1986, Journal of immunology.

HLA-DR4-associated haplotypes are genotypically diverse within HLA.

J. Silver, S. Holbeck, J. Hansen, 1985, Journal of immunology.

A PHASE I‐II STUDY EVALUATING THE MURINE ANTI‐IL-2 RECEPTOR ANTIBODY 2A3 FOR TREATMENT OF ACUTE GRAFT‐VERSUS-HOST DISEASE

K. Sullivan, R. Storb, F. Appelbaum, 1990, Transplantation.

HLA-Dw clusters associated with DR4 in Israeli Jews and the definition of a new DR4 associated Dw subtype: Dw"SHA".

J. Hansen, C. Brautbar, S. Battat, 1987, Human immunology.

HLA-Dw"SHY": a new lymphocyte defined specificity associated with HLA-DRw10.

J. Hansen, C. Brautbar, E. Mickelson, 1984, Human immunology.

Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease.

R. Storb, J. Hansen, E. Vitetta, 1988, Bone marrow transplantation.

Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease.

H. Deeg, K. Sullivan, R. Storb, 1984, Human immunology.

Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene.

S. Holbeck, J. Hansen, G. Nepom, 1985, Proceedings of the National Academy of Sciences of the United States of America.

HLA-DR molecules enhance signal transduction through the CD3/Ti complex in activated T cells.

G. Schieven, J. Ledbetter, J. Hansen, 1991, Tissue antigens.

Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphism.

Ming-Tseh Lin, J. Hansen, L. Tseng, 2002, Journal of immunological methods.

Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese.

J. Hansen, L. Tseng, P. Martin, 2001, Tissue antigens.

Public stem cell banks: considerations of justice in stem cell research and therapy.

Aravinda Chakravarti, Stephen J O'Brien, S. O’Brien, 2003, The Hastings Center report.

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.

H. Deeg, F. Appelbaum, J. Hansen, 1985, Blood.

Donor alloreactivity may predict acute graft‐versus‐host disease in HLA‐matched bone marrow transplantation for leukemia in early remission

E. Michelson, H. Johnsen, J. Hansen, 1992, European journal of haematology.

A new human T-cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells

J. Hansen, Paul J. Martin, R. Nowinski, 2005, Immunogenetics.

Inflammatory Cytokine Profile in Individuals with Inherited Chromosomally Integrated Human Herpesvirus 6.

W. Leisenring, T. Stevens-Ayers, M. Boeckh, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cross-reactivity of anti-DRw sera evaluated by serologic studies on established B-lymphoid cell lines.

J. Hansen, B. Dupont, M. Kamoun, 1978, Transplantation proceedings.

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

J. Hansen, S. Fu, T. Hara, 1985, The Journal of experimental medicine.

In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen (9.3).

J. Hansen, L. Lum, Margaret C. Seigneuret, 1982, Cellular immunology.

Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytolytic T lymphocytes (CTL).

J. Hansen, W. Newman, L. Fast, 1981, Journal of immunology.

Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction.

J. Hansen, R. Good, N. Damle, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.

J. Hansen, M. Moore, R. Good, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.

G. Longton, J. Hansen, E. Petersdorf, 1996, Tissue antigens.

Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.

Ruth Etzioni, J. Hansen, C. Anasetti, 1994, Tissue Antigens.

The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers.

J. Hansen, B. Dupont, E. Mickelson, 1993, Tissue antigens.

Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion.

J. Hansen, G. Sale, P. Weiden, 1981, Blood.

Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

H. Deeg, M. Pepe, R. Storb, 1992, Blood.

Congenital neutropenia: Abnormal neutrophil differentiation associated withHLA

J. Hansen, R. Good, B. DuPont, 1977, Immunogenetics.

Linkage of Gene for C2 Deficiency and the Major Histocompatibility Complex MHC in Man Family Study of a Further Case 1

N. Day, J. Hansen, B. Dupont, 1976, Vox sanguinis.

E-rosette receptor in human lymphocytes.

J. Hansen, C. Anasetti, P. Martin, 1987, Methods in enzymology.

HLA antigens in black American patients with multiple sclerosis.

D. Silberberg, B. Zweiman, J. Hansen, 1977, Transplantation proceedings.

The National Marrow Donor Program with emphasis on the early years

J. Hansen, J. McCullough, H. Perkins, 2006, Transfusion.

Association of aspirin-sensitive asthma with HLA-DQw2.

D. Webb, J. Hansen, B. Nisperos, 2015, The American review of respiratory disease.

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation

B. Storer, J. Hansen, S. Spellman, 2022, Blood advances.

Unresponsiveness to skin allografts induced by tissue extracts and antilymphocytic serum.

J. Hansen, P. Kilshaw, L. Brent, 1971, Transplantation proceedings.

Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.

K. Sullivan, R. Storb, B. Storer, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors.

H. Deeg, K. Sullivan, R. Storb, 1994, Blood.

Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle

J. Singer, K. Sullivan, R. Storb, 1988 .

Treatment of aplastic anemia by bone marrow transplantation in identical twins.

J. Adamson, F. Appelbaum, P. Greenberg, 1980, Blood.

Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies.

R. Storb, J. Hansen, M. Zutter, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Human marrow transplantation: an immunological perspective.

R. Storb, J. Hansen, E. Thomas, 1987, Advances in immunology.

Specific antibody-blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment of aplastic anemia.

J. Hansen, A. Smith, P. Martin, 1985, Blood.

Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation.

J. Hansen, A. Smith, E. Petersdorf, 2001, Blood.

Antithymocyte Globulin Aplastic Anemia Conditioned by Cyclophosphamide Combined With Long-Term Follow-Up of Allogeneic Marrow Transplants in Patients With

K. Sullivan, R. Storb, F. Appelbaum, 2011 .

Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.

H. Deeg, K. Sullivan, R. Storb, 1997, Blood.

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.

J. Radich, G. Schoch, J. Hansen, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T cell depletion of donor marrow for prevention of acute graft-versus-host disease.

R. Storb, J. Hansen, E. Thomas, 1985, Haematology and blood transfusion.

Use of Flow Microfluorometry in Bone Marrow Transplantation a

J. Hansen, Paul J. Martin, E. Thomas, 1984, Annals of the New York Academy of Sciences.

Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?

H. Deeg, M. Pepe, K. Sullivan, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.

J. Hansen, E. Petersdorf, C. Anasetti, 1994, Bone marrow transplantation.

ncreasingly Frequent Diagnosis of Acute astrointestinal Graft-versus-Host Disease after llogeneic Hematopoietic Cell Transplantation

R. Storb, F. Appelbaum, J. Hansen, 2004 .

Marrow transplantation for aplastic anemia.

H. Deeg, R. Storb, F. Appelbaum, 1974, Seminars in hematology.

A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.

H. Deeg, K. Sullivan, J. Nims, 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Comparison of Immunosuppressive Therapy with Antithymocyte Globulin to Bone Marrow Transplantation in Aplastic Anemia

J. Singer, K. Sullivan, R. Storb, 1990 .

Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures.

J. Hansen, M. Moore, R. Good, 1976, Transplantation proceedings.

S. Hanash, J. Pidala, Stephanie J. Lee, 2020, Blood advances.

DR5: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

J. Hansen, M. Thomsen, N. Flomenberg, 1989 .

Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.

R. Storb, F. Appelbaum, J. Hansen, 1991, Bone marrow transplantation.

Detection of heterozygotes for congenital adrenal hyperplasia: 21-hydroxylase deficiency-a comparison of HLA typing and 17-OH progesterone response to ACTH infusion.

J. Hansen, E. Giblett, V. Kelley, 1980, The Journal of pediatrics.

Allogeneic marrow transplantation

J. Hansen, E. Petersdorf, C. Anasetti, 1993 .

The National Marrow Donor Program: how it works, accomplishments to date.

H. Perkins, J. Hansen, J. McCullough, 1989, Oncology.

Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis.

T. Koepsell, M. Wener, J. Hansen, 1994, Arthritis and rheumatism.

IMMUNOLOGIC RECOVERY IN HUMAN MARROW GRAFT RECIPIENTS GIVEN CYCLOSPORINE OR METHOTREXATE FOR THE PREVENTION OF GRAFT‐VERSUS‐HOST DISEASE

H. Deeg, H. Ochs, R. Storb, 1984, Transplantation.

Signal transduction by HLA class II antigens expressed on activated T cells

G. Schieven, J. Ledbetter, J. Hansen, 1991, European journal of immunology.

Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50.

G. Longton, J. Ledbetter, J. Hansen, 1983, Journal of immunology.

Nomenclature for factors of the HLA system, 2000.

J. Bodmer, W. Bodmer, P. Parham, 2001, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.

J. Hansen, B. Dupont, R. Good, 1976, Journal of immunology.

Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.

R. Storb, F. Appelbaum, J. Hansen, 1995, Bone marrow transplantation.

Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.

K. Sullivan, R. Storb, F. Appelbaum, 1987, Blood.

Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings.

R. Storb, J. Hansen, E. Thomas, 1981, Transplantation.

Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation.

J. Hansen, S. Ishioka, E. Mickelson, 1988, Transplantation proceedings.

J. Hansen, J. Palmer, C. Weinberg, 1984, Diabetologia.

SPECIFIC UNRESPONSIVENESS TO SKIN ALLOGRAFTS IN MICE I. Properties of Tissue Extracts and Their Synergistic Effect with Antilymphocytic Serum

J. Hansen, P. Kilshaw, L. Brent, 1973, Transplantation.

HLA antibodies as a cause of false‐positive reactions in screening enzyme immunoassays for antibodies to human T‐lymphotropic virus Type III

J. Hansen, P. Beatty, M. Sayers, 1986, Transfusion.

Involvement of the B-lymphoid system in chronic myelogenous leukaemia

V. Najfeld, J. Hansen, Paul J. Martin, 1980, Nature.

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

K. Sullivan, R. Storb, F. Appelbaum, 1983, The New England journal of medicine.

Cytokine gene polymorphisms in endemic pemphigus foliaceus: a possible role for IL6 variants.

M. Petzl-Erler, Ming-Tseh Lin, J. Hansen, 2004, Cytokine.

Lymphocyte Transformation in Vitro in Response to Mitogens and Antigens

J. Hansen, S. Cunningham‐Rundles, B. DuPont, 1976 .

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.

L. Zhao, Stephanie D Rodrigues, A. Aderem, 2008, The New England journal of medicine.

Effect of HLA mismatches on the outcome of hematopoietic transplants.

J. Hansen, E. Petersdorf, C. Anasetti, 1999, Current opinion in immunology.

Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients

K. Sullivan, R. Storb, J. Hansen, 1982 .

Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.

Kristine, H. Deeg, R. Storb, 1982, Blood.

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.

B. Storer, F. Appelbaum, J. Hansen, 2002, Blood.

Idiopathic Pneumonia Syndrome after Bone Marrow Transplantation

J. Hansen, J. Clark, M. Hertz, 1993 .

Quantitation of lymphocyte response to antigen by flow cytofluorometry.

M. Melamed, J. Hansen, T. Sharpless, 1976, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells.

G. Schieven, J. Ledbetter, J. Hansen, 1991, Human immunology.

Human mixed-lymphocyte culture reaction: genetics, specificity, and biological implications.

J. Hansen, B. Dupont, B. Dupont, 1976, Advances in immunology.

Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative disease.

J. Hansen, R. Good, A. Polliack, 1976, The American journal of medicine.

Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease

J. Hansen, B. Dupont, R. Good, 1976, Cancer.

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.

K. Sullivan, R. Storb, F. Appelbaum, 1989, The New England journal of medicine.

HLA‐D COMPATIBILITY BETWEEN PARENT AND CHILD: INCREASED OCCURRENCE IN SEVERE COMBINED IMMUNODEFICIENCY AND OTHER HEMATOPOIETIC DISEASES

J. Hansen, B. Dupont, R. Good, 1977, Transplantation.

Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens

J. Hansen, P. Martin, J. Ledbetter, 1983 .

NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.

S. Bhatia, J. Hansen, S. Davies, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors

J. Hansen, E. Petersdorf, C. Anasetti, 2013 .

Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain

Anajane G. Smith, J. Hansen, E. Petersdorf, 2004, Immunogenetics.

Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes

H. Erlich, Anajane G. Smith, J. Hansen, 2004, Immunogenetics.

Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing.

Anajane G. Smith, J. Hansen, A. Smith, 1991, Tissue antigens.

Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes.

L. Zhao, D. Geraghty, J. Hansen, 2006, Genomics.

Nomenclature for factors of the HLA system, 2000.

W R Mayr, J G Bodmer, S G Marsh, 2001, Human immunology.

Conditioning regimens in bone marrow transplantation

I. Bernstein, R. Storb, B. Sandmaier, 1991 .

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

H. Deeg, K. Sullivan, R. Storb, 1997, Blood.

D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus

Å. Lernmark, M. Lathrop, I. Kockum, 2005, Diabetologia.

Empirical evaluations of analytical issues arising from predicting HLA alleles using multiple SNPs

Lue Ping Zhao, Hongwei Wang, L. Zhao, 2011, BMC Genetics.

Lack of association of CTLA-4 +49 A/G polymorphism with predisposition to type 1 diabetes in a cohort of Egyptian families

J. Hansen, M. Mira, Ghada I. Mossallam, 2014 .

Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks.

J. Hansen, C. Larsen, E. Yunis, 2003, Tissue antigens.

Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

L. Zhao, B. Storer, E. Warren, 2012, Blood.

IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation

L. Zhao, Ming-Tseh Lin, B. Storer, 2009, Transplantation.

Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.

Ming-Tseh Lin, B. Storer, J. Hansen, 2003, The New England journal of medicine.

Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers.

C. McFarland, H. Erlich, S. Scharf, 1995, Blood.

T-cell-defined DR4 subtypes as markers for type 1 diabetes.

J. R. Rowe, J. Hansen, K. Gabbay, 1988, Human Immunology.

T-Cell Recognition of HLA Class I Molecules

J. Hansen, Z. Layrisse, P. Beatty, 1989 .

Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis.

J. Hansen, G. Nepom, B. Nepom, 1984, The Journal of clinical investigation.

Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition

E. Milner, J. Hansen, G. Nepom, 1990, The Journal of experimental medicine.

Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci.

H A Erlich, G. Ferrara, H. Erlich, 1988, Journal of immunology.

Limits of HLA mismatching in unrelated hematopoietic cell transplantation.

Effie W Petersdorf, Mari Malkki, Eric Mickelson, 2004, Blood.

A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.

J. Hansen, M. Kamoun, M. Kadin, 1981, Journal of immunology.

Effect of transfer factor therapy on mixed lymphocyte culture reactivity.

J. Hansen, B. Dupont, R. Good, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Intralesional injection of the methanol extraction residue of bacillus calmette‐guerin (MER) into cutaneous metastases of malignant melanoma

A. Huvos, H. Wanebo, J. Hansen, 1978, Cancer.

Immunologic reactivity in patients with primary operable breast cancer

H. Thaler, H. Wanebo, J. Urban, 1978, Cancer.

Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions.

J. Hansen, B. Dupont, R. Good, 1977, Blood.

HLA and leprosy in Koreans.

J. Hansen, I. Choi, B. Nisperos, 2008, Tissue antigens.

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation

Benjamin D. Heavner, B. Storer, D. Geraghty, 2021, Frontiers in Immunology.

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

J. Ritz, D. Miklos, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism.

D. Geraghty, J. Hansen, A. Ishitani, 1992, Human immunology.

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.

L. Zhao, B. Storer, E. Warren, 2012, Blood.

HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.

K. Sullivan, R. Storb, F. Appelbaum, 1988, Blood.

Marrow Transplants from Unrelated Donors for the Treatment of High-Risk Acute Leukemia

J. Sierra, J. Hansen, E. Petersdorf, 1998 .

Alloantigen Presenting Function of Normal Human CD34+ Hematopoietic Cells

J. Hansen, C. Anasetti, R. Ryncarz, 1996 .

Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates.

J. Hansen, A. Górski, P. Martin, 1986, Clinical immunology and immunopathology.

Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.

J. Hansen, J. Jason, B. Evatt, 1985, Blood.

Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate.

J. Hansen, P. Martin, G. Gjerset, 1984, Blood.

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.

R Storb, C Anasetti, K. Sullivan, 1997, Blood.

Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells.

J. Delrow, S. Heimfeld, C. Turtle, 2011, Blood.

Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

G. Longton, Anajane G. Smith, J. Hansen, 1997, Blood.

K. Sullivan, R. Storb, F. Appelbaum, 1995, Blood.

Alive in continuous remission Alive after relapse Transplant deaths ’ Causes of Death Relapse Graft failure and infection Without GVHD CMV pneumonia Other infection Hemorrhage VOD of liver CMV pneumonia Other infection Pulmonary failure With chronic GVHD Infection CMV pneumonia

K. Sullivan, R. Storb, F. Appelbaum, 2003 .

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.

H. Deeg, J. Hansen, E. Bryant, 1994, Blood.

Modulation of in vitro BFU–E growth by normal Ia-positive T cells is restricted by HLA–DR

J. Hansen, B. Torok-Storb, 1982, Nature.

Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.

P V Holland, J. Hansen, P. Holland, 1993, Blood.

Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma

M. Carrington, Kai Yu, S. Schwartz, 2014, Front. Oncol..

Immune responses in an untransfused patient with aplastic anemia: analysis of cytolytic and proliferative T cell clones.

R. Storb, J. Hansen, P. Beatty, 1984, Human immunology.

Dw14(DRB1*0404) is a Dw4-dependent risk factor for rheumatoid arthritis. Rethinking the "shared epitope" hypothesis.

T. Koepsell, J. Hansen, R. Barrington, 1991, Tissue antigens.

Alloreactive T-cell clones identify multiple HLA-DQw3 variants.

J. Hansen, G. Nepom, P. Martin, 1991, Human immunology.

T-cell clones identify three distinct epitopes associated with HLA-Dw14.

J. Hansen, G. Nepom, A. Smith, 1991, Human immunology.

Variants of HLA-DRw52 Defined by Proliferative T-Lymphocyte Clones

J. Hansen, E. Mickelson, S. Masewicz, 1989 .

Epitope mapping of the human surface suppressor/cytotoxic T cell molecule Tp32.

E. Clark, J. Ledbetter, J. Hansen, 1984, Journal of immunology.

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.

H. Deeg, K. Sullivan, R. Storb, 1996, Blood.

Collection and transportation of human bone marrow cells from unrelated donors.

J. Hansen, E. Thomas, F. Petersen, 1991, Transfusion science.

Marrow transplantation from unrelated HLA-matched volunteer donors.

R. Storb, J. Hansen, P. Beatty, 1989, Transplantation proceedings.

Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

J. Hansen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

8.2-03 Graft-versus-host reaction, relapse and survival after HLA-nonidentical marrow transplants for malignancy

R. Storb, J. Hansen, P. Beatty, 1989 .

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.

C Anasetti, T A Gooley, J. Radich, 1998, The New England journal of medicine.

Bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world. The Executive Committee of the World Marrow Donor Association.

A. Gratwohl, J. Goldman, J. Hansen, 1992, Bone marrow transplantation.

The National Marrow Donor Program

J. Hansen, J. McCullough, D. Stroncek, 1993, Transfusion.

A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.

K. Sullivan, R. Storb, F. Appelbaum, 1995, Blood.

Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements.

J. Hansen, E. Petersdorf, C. Anasetti, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recombinant granulocyte‐macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia

R. Storb, F. Appelbaum, J. Hansen, 1993, British journal of haematology.

HLA matching and hematopoietic cell transplant outcome.

J. Hansen, E. Petersdorf, E. Mickelson, 2002, Clinical transplants.

Marrow Transplantation from Donors Other Than HLA Genotypically Identical Siblings: The Immunogenetics of Acute Graft Versus Host Disease

J. Hansen, P. Beatty, B. Nisperos, 1984 .

Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.

K. Sullivan, R. Storb, F. Appelbaum, 1992, Transplantation.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

hematopoietic cell transplantation influences the risk of developing rapid airflow decline after Genetic variation in bactericidal/permeability-increasing protein

L. Zhao, W. Fan, J. Hansen, 2010 .

Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.

L. Zhao, W. Fan, J. Hansen, 2006, Blood.

Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype.

J. Hansen, S. Ishioka, E. Mickelson, 1990, Transplantation.

F. Appelbaum, J. Hansen, E. Petersdorf, 1994, Blood.

Prospective Monitoring for Alloimmunization in Cord Blood Transplantation: “Virtual Crossmatch” can be Used to Demonstrate Donor-Directed Antibodies

Anajane G. Smith, J. Hansen, S. Pereira, 2009, Transplantation.

Incidence of humoral sensitization in HLA partially mismatched hematopoietic stem cell transplantation.

K. Cao, Anajane G. Smith, J. Hansen, 2009, Tissue antigens.

Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation

L. Zhao, E. Warren, J. Hansen, 2010, Current opinion in hematology.

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.

R. Storb, F. Appelbaum, M. Flowers, 1999, Blood.

T cell receptor clonal diversity following allogeneic marrow grafting.

J. Hansen, C. Cerveny, Y. Akatsuka, 1996, Human immunology.

Somatic mutations in the HLA genes of patients with hematological malignancy.

L. P. Zhao, W. Fan, M. Loken, 2012, Tissue antigens.

Donors other than HLA-identical siblings.

R. Storb, J. Hansen, P. Beatty, 1989, Progress in clinical and biological research.

Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

S. Hanash, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of plasma CD 163 concentration with de novo-onset chronic graft-versus-host disease

S. Hanash, Stephanie J. Lee, J. Hansen, 2017 .

A clinical trial of in vitro depletion of T cells in donor marrow for prevention of acute graft-versus-host disease

R. Storb, J. Hansen, P. Martin, 1985 .

DRw52: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

J. Hansen, M. Thomsen, A. Termijtelen, 1989 .

Change in functional phenotype of cloned human alloreactive cytolytic T cells.

J. Hansen, P. Beatty, E. Mickelson, 1984, Human immunology.

Marrow transplantation from donors other than HLA identical siblings.

J. Hansen, B. Nisperos, E. Thomas, 1981, Human immunology.

The HLA system in clinical bone marrow transplantation.

J. Hansen, P. Beatty, B. Nisperos, 1984, Progress in clinical and biological research.

T-cell alloreactivity in hematopoietic stem cell transplantation.

J. Hansen, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow transplant experience for children with severe aplastic anemia.

H. Deeg, K. Sullivan, R. Storb, 1994, The American journal of pediatric hematology/oncology.

Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition.

J. Hansen, Y. Akatsuka, A. Barsoukov, 1999, Tissue antigens.

Immunosuppressive therapy of severe aplastic anemia.

R. Storb, J. Hansen, E. Thomas, 1984, Progress in clinical and biological research.

Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.

H. Deeg, R. Storb, F. Appelbaum, 1994, Bone marrow transplantation.

Comparison of Matched Unrelated and Matched Related Donor Myeloablative Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia in First Remission

F. M. Stewart, M. Sorror, F. Appelbaum, 2010, Leukemia.

HLA and Marrow Transplantation

J. Hansen, 1990 .

Nomenclature for factors of the HLA system, 2002.

Effie W Petersdorf, Arne Svejgaard, Peter Parham, 2002, Human immunology.

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, D. Tritchler, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of HLA in marrow transplantation.

J. Hansen, E. Thomas, R. Clift, 1981, Transplantation proceedings.

Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors.

Anajane G. Smith, D. Geraghty, J. Hansen, 2014, Human immunology.

Nomenclature for factors of the HLA system, 1998.

W R Mayr, J G Bodmer, S G Marsh, 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Autoimmune diseases and HLA.

J. Hansen, J. Nelson, 1990, Critical reviews in immunology.

Nomenclature for Factors of the HLA System, 1998

Arne Svejgaard, Peter Parham, Takehiko Sasazuki, 1999, Tissue antigens.

Population study of allelic diversity in the human MHC class I-related MIC-A gene

G. Longton, J. Hansen, E. Petersdorf, 1999, Immunogenetics.

Nonrandom selection of HLA-B/D recombinant gametes.

J. Hansen, B. Dupont, N. Reinsmoen, 1977, Transplantation proceedings.

Six variants of HLA-1327 identified by isoelectric focusing

J. Hansen, G. Nepom, S. Choo, 2004, Immunogenetics.

Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation

J. Hansen, E. Thomas, P. Martin, 2004, Journal of Clinical Immunology.

Molecular characterization of the HLA-Cw*0409N allele.

S. Ferrone, Anajane G. Smith, J. Hansen, 2002, Human immunology.

The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules

J. Silver, J. Hansen, S. Goyert, 1984, The Journal of experimental medicine.

The lymphocyte restimulation system: Evaluation by intra-HLA-D group priming

J. Hansen, R. Wank, D. Schendel, 1978, Immunogenetics.

Two different HLA restimulating determinants separated by recombination and titration.

J. Hansen, B. Dupont, R. Wank, 1977, Transplantation proceedings.

Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

Brian S. Iglehart, J. Ragoussis, K. Osoegawa, 2019, Human immunology.

Rheumatoid arthritis-joint report

W. Thomson, G. Ferrara, T. Sasazuki, 1992 .

DR4 and DQw3: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

K. Lundin, J. Hansen, M. Thomsen, 1989 .

Background, Goals, and Experimental Design

J. Hansen, B. Dupont, N. Flomenberg, 1989 .

Conservation of HLA class I private epitopes in macaques

E. Clark, J. Hansen, L. Gaur, 2004, Immunogenetics.

Cell-mediated lympholysis in man: identification of a common target determinant associated with HLA-B12 and Bw35.

J. Hansen, B. Dupont, R. Wank, 1977, Transplantation proceedings.

Hereditary C2 deficiency: Genetic studies and association with the HL-A system

N. Day, J. Hansen, B. Dupont, 1975, The Journal of experimental medicine.

DRw6: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

J. Hansen, N. Flomenberg, M. Honeyman, 1989 .

DQw1: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

J. Hansen, N. Flomenberg, M. Honeyman, 1989 .

Evolution of HLA class I epitopes defined by murine monoclonal antibodies: distribution in macaques.

E. Clark, J. Hansen, L. Gaur, 1986, Human immunology.

SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS

J. Hansen, A. Smith, D. Shouval, 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Antigen Society #26 Report (DR3, DR7, DQw2): Part 1

L. Contu, A. Cambon-Thomsen, M. Hammond, 1989 .

Antigenic complexity of the HLA-D region as defined by homozygous typing cells and primed lymphocyte tests.

J. Hansen, B. Dupont, N. Reinsmoen, 1977, Transplantation proceedings.

B-lymphocyte alloantigens and HLA-D determinants in a North American white population.

J. Hansen, B. Dupont, N. Reinsmoen, 1977, Transplantation proceedings.

Transplantation of hematopoietic stem cells (HSC).

J. Hansen, P. Beatty, C. Anasetti, 1987, British medical bulletin.

13th IHWS Shared Resources Joint Report. IHWG Cell and Gene Bank and reference cell panels.

Erik H. Rozemuller, Carolyn Katovich Hurley, Eric Mickelson, 2006 .

HLA-DP and HLA-DO genes in presumptive HLA-identical siblings: structural and functional identification of allelic variation.

H. Erlich, J. Hansen, G. Nepom, 1987, Journal of immunology.

T-cell Clones Recognizing Shared or Cross-Reactive Epitopes: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

J. Hansen, N. Flomenberg, D. Eckels, 1989 .

Nomenclature for Factors of the HLA System, 1998

Julia G. Bodmer, Arne Svejgaard, Peter Parham, 1999, Vox Sanguinis.

Structural analysis of an HLA-B27 functional variant, B27d, detected in American blacks.

J. Hansen, S. Choo, J. A. López de Castro, 1987, Journal of immunology.

Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27.

J. Hansen, S. Choo, J. A. López de Castro, 1987, Journal of immunology.

Nomenclature for factors of the HLA system, 2002.

W R Mayr, S G E Marsh, D E Geraghty, 2002, Tissue antigens.

14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation

A. Cambon-Thomsen, A. Velardi, J. Hansen, 2007 .

Ten HLA-DR 4 alleles defined by sequence polymorphisms within the DRB 1 first domain

Anajane G. Smith, J. Hansen, E. Petersdorf, 2022 .

A novel HLA-A*8001 allele identified in an African-American population.

J. Hansen, S. Choo, G. Starling, 1994, Human immunology.

The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.

G. Longton, Anajane G. Smith, J. Hansen, 1993, Blood.

The Role of HLA-DPB 1 Disparity in the Development of Acute Graft-Versus-Host Disease Following Unrelated Donor Marrow Transplantation

G. Longton, Anajane G. Smith, J. Hansen, 2003 .

Mixed Lymphocyte Culture Technique: Standardization of a Test‐System with 105 Responding and 105 Stimulating Lymphocytes per 1 ml

J. Hansen, A. Svejgaard, B. Dupont, 2008 .

Biochemical definition of distinct HLA haplotypes associated with juvenile rheumatoid arthritis

J. Hansen, G. Nepom, B. Nepom, 1985 .

Nomenclature for Factors of the HLA System, 2004.

Effie W Petersdorf, Arne Svejgaard, Peter Parham, 2005, Human immunology.

Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.

K. Sullivan, J. Hansen, P. Beatty, 1992, Bone marrow transplantation.

Joint Report from a Mixed Lymphocyte Culture Workshop

E. Thorsby, J. Hansen, A. Svejgaard, 2008 .

Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide.

J. Hansen, C. Anasetti, J. Tso, 1996, Journal of immunology.

Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire

William S. DeWitt, Edward J. Osborne, R. Emerson, 2017, Nature Genetics.

Biomarker Panel for Chronic Graft-Versus-Host Disease.

Philip R. Gafken, Y. Ogata, B. Storer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Biomarker Panel for Chronic Graft-Versus-Host Disease

Y. Ogata, B. Storer, Qing Zhang, 2015 .

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Sarah C. Nelson, B. Storer, E. Warren, 2017, Blood.

SYNERGISM BETWEEN IL-10 GENOTYPE OF PATIENT AND IL-10 RECEPTOR-β GENOTYPE OF DONOR

L. Zhao, Ming-Tseh Lin, B. Storer, 2005 .

Effects of exogenous interferon in cytomegalovirus infections complicating bone marrow transplantation.

J. Hansen, S. Schwartz, B. Dupont, 1976, Clinical immunology and immunopathology.

Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.

Anajane G. Smith, J. Hansen, A. Smith, 1999, Blood.

Retransplantation of marrow and hematopoietic stem cells from normal donors

J. Radich, J. Hansen, E. Petersdorf, 1997 .

Allogeneic Marrow Transplantation for the Treatment of Leukemia. Role of the Major Histocompatibility Complex

J. Hansen, P. Beatty, R. Clift, 1986 .

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

H. Deeg, R. Storb, W. Leisenring, 1994 .

Donor selection for bone marrow transplantation: the predictive value of HLA-D typing for MLR compatibility between unrelated individuals.

J. Hansen, B. Dupont, 1978, Transplantation Proceedings.

H. Deeg, M. Pepe, R. Storb, 1992 .

disease: secondary treatment A retrospective analysis of therapy for acute graft-versus-host

R. Storb, G. Schoch, J. Hansen, 2011 .

Molecular modeling of the minor histocompatibility antigen HA-1 peptides binding to HLA-A alleles.

P. Kolatkar, J. Hansen, L. Tseng, 2000, Tissue antigens.

Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.

C Anasetti, G. Longton, J. Hansen, 1993, Transplantation proceedings.

Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease

S. Mccarroll, D. Altshuler, L. Zhao, 2009, Nature Genetics.

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

J. Hansen, S. Fu, T. Hara, 1985, The Journal of experimental medicine.

Ecotaxis: the principle and its application to the study of Hodgkin's disease.

J. Hansen, B. Dupont, R. Good, 1977, Clinical and experimental immunology.

T-cell receptor polymorphisms in Tlingit Indians with rheumatoid arthritis.

J. Hansen, R. Barrington, A. Lanier, 1994, Autoimmunity.

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.

J. Pagel, Stephanie J. Lee, J. Hansen, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter]

J. Singer, J. Nemunaitis, J. Hansen, 1993 .

Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation.

J. Nemunaitis, F. Appelbaum, J. Singer, 1993, Blood.

Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.

L. Zhao, Ming-Tseh Lin, B. Storer, 2005, Blood.

Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes.

C H June, P. Rabinovitch, C. June, 1986, The Journal of clinical investigation.

Human blood T lymphocytes that suppress the mixed leukocyte culture reactivity of lymphocytes from HLA-B14 bearing individuals.

J. Hansen, B. Dupont, M. Bean, 1979, Journal of immunology.

Effect of disparity in the newly identified minor histocompatibility antigen SKH13 on the development of graft-versus-host disease after marrow transplantation from an HLA-identical sibling

Ming-Tseh Lin, V. Engelhard, E. Warren, 2000 .

Human monocyte-histiocyte differentiation antigens identified by monoclonal antibodies.

J. Hansen, M. Kamoun, M. Kadin, 1983, Clinical immunology and immunopathology.

Nomenclature for factors of the HLA system, 2004.

W. Bodmer, P. Parham, J. Trowsdale, 2005, International Journal of Immunogenetics.

Nomenclature for factors of the HLA system, 2002.

W. Bodmer, P. Parham, B. Mach, 2002, European journal of immunogenetics.

Nomenclature for factors of the HLA System, 1998.

J. Bodmer, W. Bodmer, P. Parham, 1999, Human Immunology.

The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments.

D E Geraghty, H. Orr, B. Koller, 1992, Journal of immunology.

Association of HLA in immune response to influenza-A immunization.

J. Hansen, B. Dupont, R. Good, 1979, Transplantation proceedings.

Effects of treatment regimens on post marrow transplant relapse.

K. Sullivan, R. Storb, F. Appelbaum, 1991, Seminars in hematology.

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

H. Deeg, K. Sullivan, F. Appelbaum, 1996 .

Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors.

L. Zhao, W. Leisenring, W. Fan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

disease following prior therapy or antecedent hematologic disorders syndrome: similar outcomes in patients with de novo disease and syndrome or acute myeloid leukemia arising from myelodysplastic Hematopoietic cell transplantation in patients with myelodysplastic

B. Clurman, B. Sandmaier, B. Storer, 2013 .

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.

B. Clurman, H. Deeg, R. Storb, 2007, Blood.

Successful transplantation of marrow from an HLA-A, -B, -D mismatched heterozygous sibling donor into an HLA-D-homozygous patient with aplastic anemia.

J. Hansen, B. Dupont, R. Good, 1978, Transplantation Proceedings.

Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up.

H. Ochs, K. Sullivan, R. Storb, 1988, Bone marrow transplantation.

-Cell Alloreactivity in Hematopoietic Stem ell Transplantation

J. Hansen, 2005 .

Marrow transplantation for severe aplastic anemia: the Seattle experience.

H. Deeg, R. Storb, F. Appelbaum, 1984, Progress in clinical and biological research.

Bone marrow transplantation for the treatment of hematologic diseases: status in 1992.

J. Hansen, P. Beatty, 1993, Leukemia.

Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts [letter]

H. Deeg, M. Pepe, R. Storb, 1991 .

Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.

M. Boeckh, J. Hansen, J. Chien, 2008, Blood.

hematopoietic cell transplantation for Gram-negative bacteremia and mortality after allogeneic Lipopolysaccharide binding protein promoter variants influence the risk

M. Boeckh, J. Hansen, J. Chien, 2013 .

Marrow transplants from unrelated donors.

J. Sierra, J. Hansen, E. Petersdorf, 1995, Clinical transplants.

Monoclonal antibodies recognizing human T cells: potential role for preventing graft-versus-host reactions following allogeneic marrow transplantation.

J. Hansen, M. Kamoun, W. Newman, 1981, Transplantation proceedings.

Monoclonal antibodies identifying a novel T-Cell antigen and Ia antigens of human lymphocytes

J. Hansen, R. Nowinski, P. Martin, 1980, Immunogenetics.

genotype of donor β synergism between IL-10 genotype of patient and IL-10 receptor graft-versus-host disease following hematopoietic cell transplantation: Genetic variation in the IL-10 pathway modulates severity of acute

L. Zhao, Ming-Tseh Lin, B. Storer, 2013 .

IL 10 AND IL 10 RECEPTOR GENE VARIATION AND OUTCOMES AFTER UNRELATED AND RELATED HEMATOPOIETIC CELL TRANSPLANTATION

L. Zhao, Ming-Tseh Lin, B. Storer, 2009 .

Risk Factors for Graft Rejection of Marrow Transplants From HLA Haploidentical Donors

J. Hansen, P. Beatty, C. Anasetti, 1989 .

Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.

R. Storb, J. Hansen, P. Beatty, 1990, Bone marrow transplantation.

Marrow transplantation from HLA partially matched relatives and unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1995 .

Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.

H. Deeg, M. Pepe, R. Storb, 1991, Blood.

The U.S. National Marrow Donor Program.

H. Perkins, J. Hansen, 1994, The American journal of pediatric hematology/oncology.

Exacerbation of GVHD following repeated infusion of immunocompetent donor cells.

R. Chaganti, J. Hansen, R. Good, 1977, Transplantation.

A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.

H. Deeg, K. Sullivan, R. Storb, 1995, Transplantation.

T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.

J. Hansen, P. Beatty, W. Newman, 1983, Journal of immunology.

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, L. Zhao, 2016, Blood.

PRETRANSPLANT LYMPHOCYTOTOXINS DO NOT PREDICT BONE MARROW GRAFT REJECTION

J. Hansen, P. Weiden, E. Thomas, 1978, Transplantation.

Marrow transplants from unrelated donors.

J. Hansen, E. Petersdorf, C. Anasetti, 1994, Transplantation proceedings.

Tumor necrosis factor α and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease

G. Schellenberg, Ming-Tseh Lin, E. Ramos, 2006 .

LYMPHOCYTE TRANSFORMATION IN VITRO TO PARAMYXOVIRUS ANTIGENS IN MULTIPLE SCLEROSIS

J. Hansen, B. Dupont, R. Good, 1975, The Lancet.

The indirect assay for leukocyte migration inhibitory factor (LIF)--standardization and the effect of pH.

E. Willoughby, J. Hansen, B. Dupont, 1978, Journal of immunological methods.

IgE-bearing lymphocytes and atopy in a patient with X-linked infantile agammaglobulinaemia.

J. Hansen, R. Good, M. Ballow, 1973, Lancet.

The use of cryopreserved lymphocytes for longitudinal studies of immune function and enumeration of subpopulations.

J. Hansen, M. Jewett, B. Dupont, 1976, Clinical and experimental immunology.

Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan.

F. Chang, J. Hansen, L. Tseng, 2006, Tissue antigens.

Reduced coxsackie antibody titres in Type 1 (insulin-dependent) diabetic patients presenting during an outbreak of coxsackie B 3 and B 4 infection

J. Brodsky, J. Hansen, J. Palmer, 1982, Diabetologia.

Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.

J. Singer, K. Sullivan, J. Nemunaitis, 1991, Bone marrow transplantation.

HLA and marrow transplants from unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1994 .

HLA relationships to disease.

J. Hansen, J. Schaller, 1981, Hospital practice.

Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium

S. Nutland, B. Akolkar, L. Perdue, 2010, Clinical trials.

Report of the North American Indian anthropology section

W. Knowler, D. Pettitt, W. Hoy, 1992 .

The role of HLA matching in hematopoietic cell transplantation.

T Sasazuki, T. Sasazuki, J. Hansen, 1999, Reviews in immunogenetics.

Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation.

B. Storer, J. Hansen, S. Nelson, 2020, Blood advances.

Improving hematopoietic cell transplant outcomes in a new era of genomic research.

L. Zhao, B. Storer, E. Warren, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute Gvhd Diagnosis and Adjudication in a Multicenter Trial – a Report from the BMT CTN 1202 Biorepository Study

Yi-Bin Chen, J. Hansen, W. Saber, 2019, Biology of Blood and Marrow Transplantation.

Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.

B. Safai, J. Hansen, B. Dupont, 1977, Journal of immunology.

Classic Papers and Current Comments Highlights of Leukemia Research

K. Sullivan, R. Storb, J. Bennett, 2002 .

Immunosequencing reveals diagnostic signatures of chronic viral infection in T cell memory

William S. DeWitt, R. Emerson, M. Vignali, 2015, bioRxiv.

HLA and MLC typing in patients with Hodgkin's disease.

J. Hansen, B. Dupont, R. Good, 1977, Progress in clinical and biological research.

In vitro responses of peripheral blood and spleen lymphoid cells to mitogens and antigens in childhood Hodgkin's disease.

J. Hansen, R. Good, C. Tan, 1978, Cancer research.

IMMUNOSUPPRESSIVE THERAPY AS A DETERMINANT OF TRANSPLANTATION OUTCOMES

F. Dong, J. Hansen, J. Kirklin, 1993, Transplantation.

A tribute to E. Donnall Thomas

J. Hansen, M. Brink, 2013 .

Donor alloreactivity may predict acute graft-versus-host disease in patients receiving marrow transplants from HLA identical siblings.

H. Johnsen, J. Hansen, P. Beatty, 1992, Bone marrow transplantation.

Allogeneic marrow transplantation: the Seattle experience.

J. Hansen, E. Petersdorf, C. Anasetti, 1993, Clinical transplants.

Marrow transplantation for the treatment of chronic myelogenous leukemia.

H. Deeg, K. Sullivan, R. Storb, 1986, Annals of internal medicine.

Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

K. Sullivan, J. Sierra, R. Storb, 1997, Blood.

Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.

P. Bierman, J. Vose, D. Neuberg, 1993, Blood.

Nomenclature for factors of the HLA system, 2004

W R Mayr, D E Geraghty, B Dupont, 2005, Tissue antigens.

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.

K. Sullivan, J. Hannigan, R. Storb, 1990, Blood.

J. Sierra, R. Storb, B. Storer, 2000, Bone Marrow Transplantation.

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

K. Sullivan, R. Storb, F. Appelbaum, 1989, The New England journal of medicine.

Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.

Pepe, M. Pepe, G. Longton, 1993, Blood.

Hereditary C1r Deficiency: Lack of Linkage to the HL-A Region in Two Families

N. Day, J. Hansen, B. Dupont, 1976, Journal of Immunology.

Specific blocking of MLR-stimulating determinants (HLA-D) with B-cell alloantisera: preabsorption of antibody on stimulator cells.

J. Hansen, B. Dupont, C. Whitsett, 1977, Transplantation proceedings.

Immunomagnetic depletion of CD6+ cells from bone marrow and peripheral blood.

J. Hansen, P. Martin, T. Egeland, 1990, Bone marrow transplantation.

Effect of HLA-DRB1 and DQB1 allele disparity on the development of acute graft versus host disease following unrelated donor marrow transplantation

G. Longton, Anajane G. Smith, J. Hansen, 1994 .

The IHWG cell and Gene Bank 2002: a comprehensive repository of reference reagents for analysis of the human MHC and immune regulator genes

J. Hansen, E. Mickelson, J. Pei, 2002 .

Resequencing of the human major histocompatibility complex in patients with rheumatoid arthritis and healthy controls in Alaska Natives of Southeast Alaska.

L. P. Zhao, D. Geraghty, J. Hansen, 2007, Tissue antigens.

Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.

J. Hansen, B. Dupont, R. Good, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Antigen Society #23 Report (DR4, DR9): Part 2: Serologic Typing of B-Lymphoblastoid Cell Lines: DR4 and DR9

F. Christiansen, H. Perkins, J. Hansen, 1989 .

Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.

G. Schellenberg, Ming-Tseh Lin, E. Ramos, 2006, Archives of neurology.

Multivariate Detection of Gene‐Gene Interactions

M. Perlman, C. Kooperberg, I. Rajapakse, 2012, Genetic epidemiology.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

Southern Blot Analysis of Rheumatoid Arthritis

Anajane G. Smith, J. Hansen, N. Mehra, 1989 .

Quantitation of lymphocyte proliferative response to allogeneic cells and phytohemagglutinin by flow cytofluorometry. II. Comparison with [14C]thymidine incorporation.

M. Melamed, J. Hansen, B. Dupont, 1976, Clinical immunology and immunopathology.

Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.

J. Ledbetter, J. Hansen, N. Odum, 1993, Human immunology.

Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.

G. Longton, J. Hansen, A. Smith, 1993, Transplantation proceedings.

Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation

L. Zhao, E. Warren, J. Hansen, 2010, Current opinion in hematology.

A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro

J. Hansen, E. Vitetta, P. Martin, 1985 .